Home » Newsletters » BioWorld

BioWorld

Feb. 11, 1992

View Archived Issues

G-CSF Preferable in Some Cases

Regenerons CNTF Designated Orphan Drug

MEDICORP ACQUIRES TECHNOLOGY RIGHTS

FDA APPROVES ONCOR CANCER DIAGNOSTIC

INJECTABLE SMOKING DRUG ENTERS PHASE II

IPIC TO COLLABORATE WITH OHIO STATE

PROCYTE DISCUSSES WOUND-HEALING COMPOUND

ALPHA 1 TAKES $1 MILLION ORDER

STERLING WINTHROP LICENSES BIOMIRA MAbs

MGI HALTS CHEMOPROTECTIVE TRIALS

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026